List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.
The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration.
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback